1Vaux DL, Cory S, Adams JM. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-Myc to immortalise pre-B cells. Nature, 1988, 335(6189): 440~442
2Hockenbery DM, Oltvai ZN, Yin XM, et al. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell, 1993,75(2): 241~251.
3Lam M, Dubyak G, Chen L, et al. Evidence that Bcl-2 represses apoptosis by regulating endoplasmic reticulum-associated Ca2+ fluxes. Proc Natl Acad Sci USA, 1994, 91(14): 6569~6573.
4Kluck RM, Bossy-Wetzel E, Green DR, et al. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science, 1997, 275(5303):1132~1136.
5Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell dearth. Cell, 1993, 74(4): 609~619.
61 Tsujimoto Y, Finger LR, Yunis J, et al. Cloning of the chromosome breakpoint of neoplastic B cells with the t (14:18) chromosome translocation. Science, 1984, 226 (4768): 1097~1099.
6Brummel kamp TR, Ni jman SM, Dirac AM, et al. Loss of the cylin dromatosis tumor suppressor inhibits apoptosis by activating NF-kappa B[J]. Nature,2003,424:738-739.
7HuaZou.Ahuman. Protein homologous to C. Elegonsced-4, partici- Pates in cytoehrome -c-dePendent,activation of caspase-3 Cell [J]. Med Pediatr Oneol, 2006,90:405 -413.
8Ilmore TD. The Rel / nf-kappa B / I kappa B signal tmnsduction path- way and cancer[J]. Cancer Treat Res, 2006,115:241-265.
9Chaud hary, P.M, M.T. Eby, A. Jasmin, et al. Activation of the NF-kappaB pathway by caspase-3 and its homologs [J]. Oncogene, 2005,19:4451-4460.
10Gruker BM. Trcmscription factor NF-kB: a new perspective in anti- cancer therapy[J]. Postepy Biochem, 2004.50(2): 118-130.